Sativex Expected To Be Approved For Treatment Of MS

News: UK-based GW Pharmaceuticals' cannabis-derived drug Sativex (nabiximols) is likely to be approved for medical purposes in Finland, YLE has reported. National pharmaceutical agency Fimea's decision on Sativex for the treatment of spasticity associated with multiple sclerosis is expected in the next few weeks. If it is approved, the drug will be available in Finland upon prescription from a doctor on case-by-case basis. Sativex, which has already been approved in Sweden, is believed to provide several benefits, including relief from pain and stimulation of appetite.

Sativex Expected To Be Approved For Treatment Of MS

News: UK-based GW Pharmaceuticals' cannabis-derived drug Sativex (nabiximols) is likely to be approved for medical purposes in Finland, YLE has reported. National pharmaceutical agency Fimea's decision on Sativex for the treatment of spasticity associated with multiple sclerosis is expected in the next few weeks. If it is approved, the drug will be available in Finland upon prescription from a doctor on case-by-case basis. Sativex, which has already been approved in Sweden, is believed to provide several benefits, including relief from pain and stimulation of appetite.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.